Clinical Trial Update: Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating home administration of a single-use auto-injector for benralizumab in asthma; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-11-02